180 related articles for article (PubMed ID: 37346407)
1. Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma.
Duan X; Du H; Yuan M; Liu L; Liu R; Shi J
Exp Ther Med; 2023 Jul; 26(1):331. PubMed ID: 37346407
[TBL] [Abstract][Full Text] [Related]
2. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs.
Wang G; Zhang X; Feng W; Wang J
Front Genet; 2022; 13():917935. PubMed ID: 35692813
[No Abstract] [Full Text] [Related]
5. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma.
Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X
Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
8. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
[No Abstract] [Full Text] [Related]
10. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas.
Liu B; Liu Z; Feng C; Tu C
Front Genet; 2022; 13():899545. PubMed ID: 35795204
[No Abstract] [Full Text] [Related]
11. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
[TBL] [Abstract][Full Text] [Related]
12. Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma.
Zhang L; Zong L; Li W; Ning L; Zhao Y; Wang S; Wang L
Front Genet; 2023; 14():1120827. PubMed ID: 37124619
[No Abstract] [Full Text] [Related]
13. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
14. Developing a novel necroptosis-related signature to evaluate the prognostic and therapeutic characteristics of esophageal cancer.
Chen M; Hua T; Yang L; Li C; Xu S; Zhu J; Zhao T
Am J Transl Res; 2023; 15(8):5425-5445. PubMed ID: 37692951
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer.
Duan X; Hou R; Huang Y; Wang C; Liu L; Du H; Shi J
Transl Oncol; 2024 May; 46():101983. PubMed ID: 38797018
[TBL] [Abstract][Full Text] [Related]
16. A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
Lv J; Xu Q; Wu G; Hou J; Yang G; Tang C; Qu G; Xu Y
Front Genet; 2022; 13():948254. PubMed ID: 36212132
[No Abstract] [Full Text] [Related]
17. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
Front Genet; 2022; 13():966896. PubMed ID: 36186456
[No Abstract] [Full Text] [Related]
19. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer.
Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L
Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718
[TBL] [Abstract][Full Text] [Related]
20. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
